Association of polymorphisms in NFE2L2 gene encoding transcription factor Nrf2 with multifactorial diseases


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Protein transcription factor Nrf2 is a master regulator of cytoprotection. Nrf2 launches the expression of more than 100 genes of antioxidant protection and xenobiotic detoxification under oxidative stress conditions. The effect of Nrf2 induction is being intensively investigated in various multifactorial diseases that are accompanied by oxidative stress and cell death. In order to properly find a disease, which can be managed using the Nrf2-targeting therapy, it is essential to demonstrate a link between allele polymorphisms of the NFE2L2 gene, which encodes the Nrf2 protein, and the changed risk for the development of a disease. Here we review the studies of Nrf2 polymorphism in respiratory diseases (asthma, pneumonia) and associated critical illnesses, cardiovascular diseases, sex-specific reproductive disorders, gastrointestinal diseases, diabetes, obesity, neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases, epilepsy, and retinopathy. The results of the studies strongly indicate that transcription factor Nrf2 is responsible for the pathogenesis of various multifactorial diseases.

作者简介

L. Porokhovnik

Research Centre for Medical Genetics

编辑信件的主要联系方式.
Email: med-gen@mail.ru
俄罗斯联邦, Moscow, 115478

V. Pisarev

Negovsky Research Institute of General Reanimatology; Rogachev Federal Research and Clinical Centre of Pediatric Hematology, Oncology, and Immunology; Central Research Institute of Epidemiology

Email: med-gen@mail.ru
俄罗斯联邦, Moscow, 107031; Moscow, 117997; Moscow, 111123


版权所有 © Pleiades Publishing, Inc., 2017
##common.cookie##